Delta-Fly Pharma, Inc. (4598.T)

JPY 456.0

(0.0%)

Operating Expenses Summary of Delta-Fly Pharma, Inc.

  • Delta-Fly Pharma, Inc.'s latest annual operating expenses in 2023 was 1.4 Billion JPY , up 6.66% from previous year.
  • Delta-Fly Pharma, Inc.'s latest quarterly operating expenses in 2024 Q1 was 497 Thousand JPY , down -4.79% from previous quarter.
  • Delta-Fly Pharma, Inc. reported a annual operating expenses of 1.31 Billion JPY in annual operating expenses 2022, up 4.31% from previous year.
  • Delta-Fly Pharma, Inc. reported a annual operating expenses of 1.26 Billion JPY in annual operating expenses 2021, up 9.48% from previous year.
  • Delta-Fly Pharma, Inc. reported a quarterly operating expenses of 1.4 Billion JPY for 2023 FY, up 6.66% from previous quarter.
  • Delta-Fly Pharma, Inc. reported a quarterly operating expenses of 275.57 Million JPY for 2023 Q1, down -4.79% from previous quarter.

Annual Operating Expenses Chart of Delta-Fly Pharma, Inc. (2023 - 2019)

Historical Annual Operating Expenses of Delta-Fly Pharma, Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 1.4 Billion JPY 6.66%
2022 1.31 Billion JPY 4.31%
2021 1.26 Billion JPY 9.48%
2020 1.15 Billion JPY -30.25%
2019 1.65 Billion JPY 0.0%

Peer Operating Expenses Comparison of Delta-Fly Pharma, Inc.

Name Operating Expenses Operating Expenses Difference
KOHJIN BIO CO LTD 1.28 Billion JPY -9.264%
PRISM BioLab Co.,LTD 576.81 Million JPY -143.313%
GNI Group Ltd. 9.32 Billion JPY 84.945%
Linical Co., Ltd. 2.7 Billion JPY 48.12%
Trans Genic Inc. 2.15 Billion JPY 35.02%
MEDINET Co., Ltd. 1.49 Billion JPY 5.881%
Soiken Holdings Inc. 3.07 Billion JPY 54.301%
Cytori Cell Research Institute, Inc. 1.85 Billion JPY 24.422%
AnGes, Inc. 8.9 Billion JPY 84.235%
OncoTherapy Science, Inc. 943.08 Million JPY -48.817%
Nxera Pharma Co., Ltd. 19.19 Billion JPY 92.686%
Immuno-Biological Laboratories Co., Ltd. 412.99 Million JPY -239.83%
NanoCarrier Co., Ltd. 975.37 Million JPY -43.89%
Carna Biosciences, Inc. 2.56 Billion JPY 45.339%
CanBas Co., Ltd. 278 Million JPY -404.843%
D. Western Therapeutics Institute, Inc. 1.14 Billion JPY -22.945%
RaQualia Pharma Inc. 1.81 Billion JPY 22.8%
Chiome Bioscience Inc. 1.6 Billion JPY 12.489%
Kidswell Bio Corporation 2.37 Billion JPY 40.883%
PeptiDream Inc. 9.68 Billion JPY 85.512%
Oncolys BioPharma Inc. 1.96 Billion JPY 28.416%
Ribomic Inc. 1.1 Billion JPY -26.931%
SanBio Company Limited 4.53 Billion JPY 69.08%
Healios K.K. 3.48 Billion JPY 59.752%
BrightPath Biotherapeutics Co., Ltd. 1.15 Billion JPY -21.54%
Kubota Pharmaceutical Holdings Co., Ltd. 1.33 Billion JPY -5.17%
StemRIM 2.07 Billion JPY 32.396%
CellSource Co., Ltd. 1.96 Billion JPY 28.522%
FunPep Company Limited 313.82 Million JPY -347.218%
Kringle Pharma, Inc. 958.01 Million JPY -46.497%
Stella Pharma Corporation 963.98 Million JPY -45.59%
TMS Co., Ltd. 943.25 Million JPY -48.79%
Noile-Immune Biotech Inc. 1.08 Billion JPY -28.764%
Cuorips Inc. 598.11 Million JPY -134.647%
K Pharma,Inc. 543.94 Million JPY -158.017%
Takara Bio Inc. 23.9 Billion JPY 94.129%
ReproCELL Incorporated 1.51 Billion JPY 7.302%
PhoenixBio Co., Ltd. 1.18 Billion JPY -18.537%
StemCell Institute Inc. 1.16 Billion JPY -20.767%
Japan Tissue Engineering Co., Ltd. 1.52 Billion JPY 7.805%
CellSeed Inc. 804.93 Million JPY -74.358%